Dr. Annelien Tits
ActiveSummary
Dr. Annelien Tits has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €98,986 and a net result of €47,333. Its solvency ranks better than 74% of 20,558 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Overview
- Equity
- €98,986
- Profit
- €47,333
Why 98raises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 6.25, cash €46,869Figures for financial year 2025 (filed 17-07-2026)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 83% on liquidity, 80% on profitability and 89% on growth.
The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
This company filed its last 2 accounts on average 10 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
- Annual accounts filedfinancial year 2025 · micro…
- Annual accounts filedfinancial year 2024 · micro…
- Registered officeRegistered-office move · Director in…
Financials · financial year 2025, micro format
2024 to 2025, 2 financial years
The operating result rises in 2025; 2025 is 3% above 2024.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 39,278 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 95.8% are still going.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 39,278 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,460 | €229 | ▼ 84.3% |
| Other operating charges640/8 | €141 | - | - |
| Gross operating margin9900 | €60,515 | €60,930 | ▲ 0.7% |
| Operating profit (loss)9901 | €58,915 | €60,702 | ▲ 3.0% |
| Financial income75/76B | - | €1 | - |
| Recurring financial income75 | - | €1 | - |
| Financial charges65/66B | €62 | €266 | ▲ 331% |
| Recurring financial charges65 | €62 | €266 | ▲ 331% |
| Profit (loss) for the period before taxes9903 | €58,853 | €60,437 | ▲ 2.7% |
| Income taxes67/77 | €12,200 | €13,104 | ▲ 7.4% |
| Profit (loss) for the period9904 | €46,653 | €47,333 | ▲ 1.5% |
| Profit (loss) for the period to be appropriated9905 | €46,653 | €47,333 | ▲ 1.5% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €67,336 | €118,790 | ▲ 76.4% |
| Formation expenses20 | - | €0 | - |
| Fixed assets21/28 | €229 | - | - |
| Intangible fixed assets21 | €229 | - | - |
| Current assets29/58 | €67,108 | €118,790 | ▲ 77.0% |
| Amounts receivable within one year40/41 | €6,308 | €17,091 | ▲ 171% |
| Trade receivables40 | €3,308 | €10,191 | ▲ 208% |
| Other amounts receivable41 | €3,000 | €6,900 | ▲ 130% |
| Current investments50/53 | - | €50,000 | - |
| Cash at bank and in hand54/58 | €60,569 | €46,869 | ▼ 22.6% |
| Deferred charges and accrued income490/1 | €231 | €4,830 | ▲ 1,993% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €67,336 | €118,790 | ▲ 76.4% |
| Equity10/15 | €51,653 | €98,986 | ▲ 91.6% |
| Contributions10/11 | €5,000 | €5,000 | = |
| Contributions outside capital11 | €5,000 | - | - |
| Other1109/19 | €5,000 | - | - |
| Profit (loss) carried forward14 | €46,653 | €93,986 | ▲ 101% |
| Amounts payable17/49 | €15,683 | €19,804 | ▲ 26.3% |
| Amounts payable within one year42/48 | €15,072 | €18,992 | ▲ 26.0% |
| Trade debts44 | €6,544 | €6,499 | ▼ 0.7% |
| Suppliers440/4 | €6,544 | €6,499 | ▼ 0.7% |
| Taxes, remuneration and social security45 | €7,200 | €8,704 | ▲ 20.9% |
| Taxes450/3 | €7,200 | €8,704 | ▲ 20.9% |
| Other amounts payable47/48 | €1,328 | €3,788 | ▲ 185% |
| Accrued charges and deferred income492/3 | €611 | €812 | ▲ 32.8% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €46,653 | €47,333 | ▲ 1.5% |
| + Depreciation and write-downs630 | €1,460 | €229 | ▼ 84.3% |
| Operating cash flow (approximation) | €48,113 | €47,562 | ▼ 1.1% |
| Change in cash | - | -€13,700 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Filings with the National Bank (2)
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | micro format | 17-07-2026 | 2026-00303543 |
| 31-12-2024 | micro format | 25-07-2025 | 2025-00306632 |
Similar companies · same sector, comparable size
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Mandate history
- Board
| Name | Functions and periods |
|---|---|
| TITS Annelien |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.
Group and network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
History
Acts, filings and financial milestones
22-01
Gazette deed
Registered officeRegistered-office move · Director in office3 facts ▸
- Registered-office move, Vinkenlaan 25 te 9250 Waasmunster
- Board meeting, 05-12-2024
- Director in office, Annelien Tits (sole director)
26-02
Gazette deed
IncorporationAppointment: TITS Annelien (director) · Registered office clause · Board rule9 facts ▸
- Registered office clause, “9140 Temse, Sint-Amelbergalaan 20” (deed in Dutch)
- Board rule, 1
- Director appointment, TITS Annelien (director (not named in the articles))
- Other provision, “geen verbodsbepaling bestuursmandaat, niet getroffen door enige verbodsbepaling voor uitoefening bestuursmandaat” (deed in Dutch)
- Pre-incorporation commitments, “takeover, alle verbintenissen, verplichtingen en activiteiten in naam en voor rekening vennootschap in oprichting” (deed in Dutch)
- Founder, TITS Annelien Daisy Yvette Jos (comparant)
- Incorporation, “Dr. Annelien Tits” (deed in Dutch)
- Founding capital, €5,000
- Other provision, 20-02-2024
Register details
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 21 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
2 establishment units
2 parcels
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 42023A0949/00D000 | Flanders | 2,425 m² | 1 · 206 m² | 24.5 m · 2 |
| 46025B1103/00G002 | Flanders | 390 m² | 1 · 204 m² | 9.9 m · 2 |
How the parcels are linked
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder die nuttig of nodig zijn voor de uitoefening van voormelde…” (deed in Dutch)
4 activities (deed in Dutch)
- Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder die nuttig of nodig zijn voor de uitoefening van voormelde activiteit;
- De aankoop,het huren en/of leasen van alle medische apparatuur en begeleidende accommodaties,inclusief gebouwen,kortom van een volledige materiële infrastructuur om deze ter beschikking te stellen van de arts-aandeelhouder;
- Het scheppen van de mogelijkheden om de arts-aandeelhouder toe te laten zich verder te bekwamen in voormelde medische discipline,dit teneinde een kwalitatief hoogstaande praktijkuitoefening mogelijk te maken.
- Het verstrekken van informatie en/of onderricht inzake gezondheidszorgen dit in de breedste betekenis van het woord,zonder dat dit de vorm van een aanvullende commerciële activiteit mag aannemen.
- DurationHow long the company exists; usually unlimited, so until it is dissolved.
- Unlimited
- Name clauseThe name the company operates under according to its articles.
- Dr. Annelien Tits
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Vlaamse Gewest, bij enkel besluit bestuursorgaan administratieve zetels,agentschappen,werkhuizen,stapelplaatsen en bijkantoren in België of…” (deed in Dutch)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Last Saturday of June
Oversight and winding up
- Statutory auditorA statutory auditor is a registered auditor who checks the accounts; small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- “Ontbinding op elk moment door algemene vergadering in vormen statutenwijziging, na aanzuivering schulden, lasten, kosten of consignatie en…” (deed in Dutch)